Journal of Oncology
Overview
The Journal of Oncology is a peer-reviewed publication dedicated to advancing the understanding and treatment of cancer. It provides a platform for researchers, clinicians, and scientists to share their latest findings, innovative approaches, and clinical trials in the field of oncology. With a focus on multidisciplinary research, this journal aims to contribute to the development of effective strategies for cancer prevention, diagnosis, and treatment.
Details
Recent Articles
1.
Hernandez-Nava E, Montano L, Rendon-Huerta E
J Oncol
. 2024 Sep;
2021:5936905.
PMID: 39296813
Gastric cancer is a heterogeneous disease that represents 5% to 10% of all new cancer cases worldwide. Advances in histological diagnosis and the discovery of new genes have admitted new...
2.
Lu Y, Yang J, Zhu J, Shu Y, Zou X, Ruan Q, et al.
J Oncol
. 2024 Sep;
2023:4616682.
PMID: 39282225
Oral squamous cell carcinoma (OSCC) is one of the common malignant tumors in the head and neck, characterized by high malignancy, rapid growth and metastasis, high invasive ability, and high...
3.
Kang P, Yu H, Li Y, Wen X, Ye H, Luo Y, et al.
J Oncol
. 2024 Sep;
2023:3221510.
PMID: 39282224
Hypofractionated radiotherapy (HFRT) or chemotherapy combined with programmed death-1 (PD-1) blockade has achieved good clinical control in advanced nonsmall cell lung cancer (NSCLC). However, the relative influence of HFRT + ...
4.
Kang Z, Li W, Yu Y, Yang J
J Oncol
. 2024 Sep;
2022:7711555.
PMID: 39280893
Objective: To compare the effects of different treatment strategies for metastatic hormone-sensitive prostate cancer (mHSPC) using a network meta-analysis. Methods: English databases (PubMed, Embase, and medRxiv) and Chinese databases (Wanfang...
5.
Sun K, Fei X, Xu M, Xu R, Xu M
J Oncol
. 2024 Sep;
2022:9499317.
PMID: 39280892
Low-grade gliomas (LGGs) are primary invasive brain tumors that grow slowly but are incurable and eventually develop into high malignant glioma. Fc fragment of IgG receptor IIIa (FCGR3A) gene polymorphism...
6.
Wu X, Han H, Zhang C, Song W
J Oncol
. 2024 Sep;
2022:6211059.
PMID: 39280891
Background: Several novel androgen receptor antagonists have been introduced into the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). We conducted a meta-analysis to evaluate the survival and safety of the...
7.
Guo Y, Li Z, Sun W, Gao W, Liang Y, Mei Z, et al.
J Oncol
. 2024 Sep;
2022:8268719.
PMID: 39280890
Background: Tumor-associated macrophages (TAMs) are M2-like phenotype macrophages which contribute to the tumor progression in tumor microenvironment. The precise mechanisms of TAMs were intricated, and recently, it has been illustrated...
8.
Nakahashi H, Oda T, Shimomura O, Akashi Y, Takahashi K, Miyazaki Y, et al.
J Oncol
. 2024 Mar;
2024:1529449.
PMID: 38528852
Aberrant glycosylation in tumor cells is a hallmark during carcinogenesis. KRAS gene mutations are the most well-known oncogenic abnormalities but their association with glycan alterations in pancreatic ductal adenocarcinoma (PDAC)...
9.
Barman S, Sen M, Mahns D, Wu M, Malladi C
J Oncol
. 2024 Jan;
2024:9925970.
PMID: 38249992
Zinc dyshomeostasis is manifested in breast and prostate cancer cells. This study attempted to uncover the molecular details prodded by the change of extracellular zinc by employing a panel of...
10.
Hayashi D, Shirai T, Terauchi R, Tsuchida S, Mizoshiri N, Mori Y, et al.
J Oncol
. 2023 Dec;
2023:5445802.
PMID: 38130464
Osteosarcoma is a rare malignant tumor that commonly occurs in children. Anticancer drugs, for example, cisplatin, aid in postsurgery recovery but induce side effects such as renal damage, affecting the...